RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Paramyxoviridae Infections
Accession: DOID:9007244
browse the term
Definition: Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.
Synonyms: exact_synonym: Parainfluenza; Parainfluenza Virus Infection; Parainfluenza Virus Infections; Paramyxoviridae Infection
primary_id: MESH:D018184 ; RDO:0006283
For additional species annotation, visit the
Alliance of Genome Resources .
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased expression:nasal mucus (human)
RGD
PMID:20182399
RGD:4891406
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:20053825
RGD:4891886
NCBI chr 6:19,312,351...19,324,439
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:nasal mucus
RGD
PMID:20182399
RGD:4891406
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,495...71,670,271
G
B2M
beta-2-microglobulin
ISO
protein:increased expression:plasma
RGD
PMID:1402029
RGD:6482707
NCBI chr 1:126,865,767...126,878,501
Ensembl chr 1:126,835,143...126,981,582
G
CD46
CD46 molecule, complement regulatory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8402913
NCBI chr 9:135,025,439...135,078,910
G
MUC1
mucin 1, cell surface associated
severity
ISO
protein:increased expression:serum
RGD
PMID:11802251
RGD:5131281
NCBI chr 4:94,626,317...94,631,194
G
MAVS
mitochondrial antiviral signaling protein
severity
ISO
RGD
PMID:25953917
RGD:40903044
NCBI chr17:31,850,646...31,869,273
Ensembl chr17:31,850,155...31,869,187
G
PCD1B
CD1B antigen
ISO
protein:decreased expression:alveolar macrophage, monocyte (mouse)
RGD
PMID:32463330
RGD:127345107
NCBI chr 4:92,035,122...92,040,724
G
TREM2
triggering receptor expressed on myeloid cells 2
ISO
ClinVar Annotator: match by term: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1
ClinVar
PMID:12080485 PMID:12754369 PMID:12925681 PMID:15883308 PMID:18546367 PMID:21834902 PMID:23150934 PMID:23318515 PMID:23399524 PMID:24899047 PMID:24990881 PMID:25615530 PMID:25741868 PMID:27995897 PMID:28492532 PMID:28559417 PMID:28768830 PMID:29142083 PMID:29557178 More...
NCBI chr 7:36,465,921...36,471,509
Ensembl chr 7:36,464,034...36,471,516
G
TYROBP
transmembrane immune signaling adaptor TYROBP
ISO
ClinVar Annotator: match by term: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1
OMIM ClinVar
PMID:10888890 PMID:11109371 PMID:12370476 PMID:15883308 PMID:17125796 PMID:20500450 PMID:22082900 PMID:27658901 PMID:28492532 PMID:28620717 More...
NCBI chr 6:45,309,199...45,312,562
Ensembl chr 6:45,309,197...45,312,537
G
IL21
interleukin 21
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:22238461
RGD:6892925
NCBI chr 8:101,532,742...101,540,712
Ensembl chr 8:101,530,949...101,540,738
G
IL21R
interleukin 21 receptor
ISO
RGD
PMID:22238461
RGD:6892925
NCBI chr 3:19,447,488...19,489,201
Ensembl chr 3:19,443,344...19,489,152
G
PDCD1
programmed cell death 1
treatment
ISO
associated with reinfection
RGD
PMID:25339663
RGD:40822811
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,210...140,347,478
G
ACE2
angiotensin converting enzyme 2
severity treatment
ISO
human protein in a mouse model
RGD
PMID:26813885
RGD:32716392
NCBI chr X:12,099,849...12,152,204
Ensembl chr X:12,099,853...12,151,275
G
AICDA
activation induced cytidine deaminase
treatment
ISO
RGD
PMID:27721128
RGD:127285642
NCBI chr 5:62,777,236...62,787,342
Ensembl chr 5:62,777,352...62,787,483
G
CCL1
C-C motif chemokine ligand 1
ISO
mRNA:increased expression:lung
RGD
PMID:11134301
RGD:4891417
NCBI chr12:40,728,014...40,731,411
Ensembl chr12:40,728,014...40,731,411
G
CCL11
chemokine (C-C motif) ligand 11
ISO
RGD
PMID:10955955
RGD:4145447
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
G
CCL17
C-C motif chemokine ligand 17
ISO
mRNA:increased expression:lung
RGD
PMID:17641031
RGD:4145495
NCBI chr 6:19,345,929...19,372,972
Ensembl chr 6:19,345,941...19,348,926
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:altered expression:lung, T cell (mouse)
RGD
PMID:19124761
RGD:4891880
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CCR5
C-C motif chemokine receptor 5
ISO
protein:increased expression:blood, monocyte (human) DNA:snps:5' utr:g.-2459A>G, g.-2554G>T (human)
RGD
PMID:12964123 PMID:18439876
RGD:4892079 RGD:4892113
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,902
G
CD274
CD274 molecule
severity
ISO
protein:increased expression: lung
RGD
PMID:25465101
RGD:11056952
NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,047...216,792,724
G
CD28
CD28 molecule
ISO
RGD
PMID:18056387
RGD:5131621
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,208...107,162,943
G
CFTR
CF transmembrane conductance regulator
ISO
DNA:mutation: :
RGD
PMID:20015999
RGD:4140389
NCBI chr18:28,627,717...28,818,209
Ensembl chr18:28,627,728...28,817,950
G
CX3CR1
C-X3-C motif chemokine receptor 1
severity
ISO
RGD
PMID:12941892 PMID:16424189
RGD:4892016 RGD:4892018
NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:18624292
RGD:5135483
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:nasopharynx(human)
RGD
PMID:29325581
RGD:150521551
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:15916706
RGD:5135444
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,495...71,670,271
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:18624292
RGD:5135483
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
G
DNASE1
deoxyribonuclease 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28780505
NCBI chr 3:38,590,045...38,646,852
Ensembl chr 3:38,586,600...38,646,834
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism protein:increased secretion:nasopharynx
CTD RGD
PMID:17425601 PMID:20209309
RGD:4140425
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism associated with Otitis media;protein:increased expression:serum:
CTD RGD
PMID:19352211 PMID:21937650
RGD:8142352
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,848...32,482,752
G
IL10
interleukin 10
severity
ISO
RGD
PMID:20209309
RGD:4140425
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,727...67,405,711
G
IL13
interleukin 13
ISO
RGD
PMID:18250447
RGD:4145641
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
G
IL17A
interleukin 17A
severity
ISO
protein:increased expression:plasma
RGD
PMID:19738511
RGD:4889103
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL18
interleukin 18
ISO
DNA:polymorphism:intron:rs360721 (human)
RGD
PMID:18043444 PMID:20130064
RGD:4889550 RGD:4889584
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,966...39,873,300
G
IL1RL1
interleukin 1 receptor like 1
ISO
RGD
PMID:11283151
RGD:5144238
NCBI chr 3:51,868,549...51,902,454
Ensembl chr 3:51,803,165...51,951,383
G
IL27
interleukin 27
ameliorates
ISO
RGD
PMID:22301139
RGD:126790525
NCBI chr 3:18,421,962...18,427,916
Ensembl chr 3:18,421,981...18,427,915
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:20639494
RGD:5147443
NCBI chr10:64,948,149...65,001,320
Ensembl chr10:64,948,552...65,001,173
G
IL33
interleukin 33
ISO
RGD
PMID:26044350 PMID:28771101
RGD:11342984 RGD:39939029
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,435...215,941,840
G
IL5
interleukin 5
severity
ISO
RGD
PMID:25410867
RGD:11354937
NCBI chr 2:134,832,143...134,846,141
Ensembl chr 2:134,832,147...134,835,212
G
IL5RA
interleukin 5 receptor subunit alpha
ISO
protein:decreased expression:blood, eosinophil
RGD
PMID:16734609
RGD:5128618
NCBI chr13:59,651,184...59,692,211
Ensembl chr13:59,652,755...59,690,184
G
IL6
interleukin 6
severity
ISO
protein:increased expression:nasal mucus associated with Otitis media;protein:increased expression:serum:
RGD
PMID:19352211 PMID:20622030
RGD:4143259 RGD:8142352
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,340...91,511,263
G
IL9
interleukin 9
susceptibility
ISO
DNA:SNPs: :rs2069885, rs1799962 (human)
RGD
PMID:19915054 PMID:20503287
RGD:5128684 RGD:5128685
NCBI chr 2:138,048,943...138,052,588
Ensembl chr 2:138,048,943...138,052,588
G
IRF1
interferon regulatory factor 1
ISO
protein:increased expression:dorsal root ganglion
RGD
PMID:20045913
RGD:5128775
NCBI chr 2:134,776,122...134,783,646
Ensembl chr 2:134,776,134...134,783,646
G
MIR21
microRNA mir-21
ameliorates
ISO
associated with asthma;
RGD
PMID:27448447
RGD:41404696
NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358
G
MMP2
matrix metallopeptidase 2
ISO
mRNA, protein:increased expression, increased activity:bronchoalveolar lavage fluid
RGD
PMID:17254480
RGD:5130726
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,594...30,086,982
G
MMP9
matrix metallopeptidase 9
ISO
mRNA, protein:increased expression, increased activity:bronchoalveolar lavage fluid
RGD
PMID:17254480
RGD:5130726
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,175,056...48,188,264
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
ISO
associated with Respiratory Hypersensitivity; protein:increased expression:lung
RGD
PMID:15130904
RGD:5131205
NCBI chr 2:757,897...790,321
G
NGF
nerve growth factor
ISO
RGD
PMID:19824047
RGD:4891065
NCBI chr 4:105,256,691...105,307,843
Ensembl chr 4:105,256,417...105,307,842
G
NGFR
nerve growth factor receptor
ISO
RGD
PMID:19824047
RGD:4891065
NCBI chr12:25,699,410...25,720,355
Ensembl chr12:25,699,427...25,720,357
G
PCD1B
CD1B antigen
ameliorates
ISO
RGD
PMID:32463330
RGD:127345107
NCBI chr 4:92,035,122...92,040,724
G
PDCD1
programmed cell death 1
ISO
protein:increased expression:CD4 Tcell, CD8 Tcell from lung: protein:increased expression: CD8 Tcell from nasal wash:
RGD
PMID:25465101
RGD:11056952
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,210...140,347,478
G
PDE12
phosphodiesterase 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26055709
NCBI chr13:39,395,517...39,402,653
Ensembl chr13:39,395,541...39,402,650
G
RIPK3
receptor interacting serine/threonine kinase 3
ameliorates
ISO
RGD
PMID:33303545
RGD:127229923
NCBI chr 7:74,951,145...74,955,255
Ensembl chr 7:74,951,060...74,955,192
G
RSAD2
radical S-adenosyl methionine domain containing 2
treatment
ISO
RGD
PMID:23018837
RGD:11554170
NCBI chr 3:128,880,853...128,897,809
Ensembl chr 3:128,877,186...128,897,847
G
SARM1
sterile alpha and TIR motif containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24478430
NCBI chr12:44,654,364...44,676,942
Ensembl chr12:44,655,811...44,676,945
G
SCGB1A1
secretoglobin family 1A member 1
ISO
RGD
PMID:12847279
RGD:5144208
NCBI chr 2:9,297,282...9,302,204
Ensembl chr 2:9,297,283...9,302,165
G
SFTPA1
surfactant protein A1
susceptibility
ISO
protein:decreased expression:lung DNA:polymorphisms, haplotype: (human)
RGD
PMID:10194154 PMID:19287351
RGD:4143439 RGD:4143495
NCBI chr14:82,091,178...82,095,393
Ensembl chr14:82,091,178...82,107,675
G
SFTPB
surfactant protein B
severity
ISO
protein:decreased expression:lung DNA:SNPs:promoter, cds, intron:-32G>T (rs2077079), p.T131I (rs1130866), 5781A>C (rs2040349) (human)
RGD
PMID:10194154 PMID:17498296
RGD:4143382 RGD:4143439
NCBI chr 3:59,101,940...59,113,442
Ensembl chr 3:59,101,952...59,111,834
G
SFTPC
surfactant protein C
ISO
DNA:polymorphism: :138A>C, 186A>G (human)
RGD
PMID:17121584 PMID:19304906
RGD:4144065 RGD:4144116
NCBI chr14:6,440,309...6,443,104
Ensembl chr14:6,440,309...6,443,095
G
SFTPD
surfactant protein D
susceptibility
ISO
protein:decreased expression:lung DNA:polymorphisms: :p.M11T, p.A160T (human
RGD
PMID:10194154 PMID:19287351
RGD:4143439 RGD:4143495
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
G
SLA-8
MHC class I antigen 8
ISO
RGD
PMID:10706505
RGD:5144121
NCBI chr 7:23,622,352...23,625,818
G
TAC1
tachykinin precursor 1
ISO
mRNA,protein:increased expression:lung
RGD
PMID:10516226
RGD:5147822
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,535...77,206,526
G
TACR1
tachykinin receptor 1
treatment
ISO
RGD
PMID:10516226
RGD:5147822
NCBI chr 3:67,839,367...68,021,733
Ensembl chr 3:67,839,411...68,021,728
G
TICAM1
toll like receptor adaptor molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24478430
NCBI chr 2:74,004,566...74,021,100
Ensembl chr 2:74,004,550...74,021,094
G
TLR2
toll like receptor 2
ISO
RGD
PMID:19019963
RGD:4889534
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,991...75,446,850
G
TLR3
toll like receptor 3
ISO
RGD
PMID:16424225
RGD:5129224
NCBI chr15:46,966,262...46,977,774
Ensembl chr15:46,966,040...47,058,734
G
TLR4
toll like receptor 4
no_association susceptibility
ISO
DNA:SNP:cds:p.D299G (human) DNA:polymorphisms:cds:p.D259G, T359I (human) DNA:SNPs:cds:p.D299G, T399I (human)
RGD
PMID:17264400 PMID:17449325 PMID:17709532 PMID:19019963
RGD:4144161 RGD:4144164 RGD:4144167 RGD:4889534
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,059,004
G
TLR6
toll like receptor 6
ISO
RGD
PMID:19019963
RGD:4889534
NCBI chr 8:30,159,744...30,180,650
Ensembl chr 8:30,159,754...30,180,650
G
TLR8
toll like receptor 8
ISO
associated with Bronchiolitis; mRNA:increased expression:nasopharynx (human)
RGD
PMID:19386802
RGD:5129471
NCBI chr X:9,551,284...9,616,762
Ensembl chr X:9,549,552...9,616,759
G
TNF
tumor necrosis factor
ISO
protein:increased expression:Bronchoalveolar lavage fluid
RGD
PMID:15791294
RGD:4145715
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,636...23,703,655
G
TSLP
thymic stromal lymphopoietin
sexual_dimorphism
ISO
mRNA:increased expression:lung (mouse) protein:increased expression:nasal mucus (human)
RGD
PMID:27156176 PMID:28471975 PMID:31076663
RGD:38549376 RGD:38596342 RGD:38596346
NCBI chr 2:115,832,152...115,837,572
G
CCL28
C-C motif chemokine ligand 28
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:17954569
RGD:4892194
NCBI chr16:27,990,024...28,010,859
Ensembl chr16:27,985,167...28,011,237
G
CCR5
C-C motif chemokine receptor 5
ISO
RGD
PMID:17641009
RGD:4892127
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,902
G
MMP9
matrix metallopeptidase 9
ISO
mRNA, protein:increased expression, increased activity:lung
RGD
PMID:16816895
RGD:5130923
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,175,056...48,188,264
G
PPIA
peptidylprolyl isomerase A
exacerbates
ISO
RGD
PMID:28594325
RGD:150429629
NCBI chr18:50,563,130...50,566,857
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISO
DNA:insertion/deletion:
RGD
PMID:16741935
RGD:40400901
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,639
G
IL29
interleukin 29 (interferon, lambda 1)
ISO
protein:increased expression:blood serum (human)
RGD
PMID:30077763
RGD:126848745
NCBI chr17:51,484,658...51,485,233
Ensembl chr17:51,484,658...51,485,233
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all